This company has been marked as potentially delisted and may not be actively trading. Apogee Therapeutics (APGE) News Today Add Compare Share Share News and Trends Stock AnalysisAnalyst ForecastsEarningsFDA EventsInsider TradesNews and TrendsOwnershipShort Interest Apogee Therapeutics Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2026 September 2026 August 2026 July 2026 June 2026 May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 Time Period More filters Fewer filters Done Paragon Labs Adds Former Apogee Leaders As Alaunos Completes Velaris Acquisition; Stock UpOctober 13, 2026 | rttnews.comApogee Therapeutics, Inc.(NasdaqGM:APGE) dropped from S&P Global BMI IndexSeptember 3, 2026 | marketscreener.comMAbbVie Closes $10.9 Billion Acquisition of Apogee TherapeuticsSeptember 3, 2026 | finance.yahoo.comApogee Therapeutics, Inc.(NasdaqGM:APGE) dropped from S&P Biotechnology Select Industry IndexSeptember 3, 2026 | marketscreener.comMAbbVie Completes $10.9 Bln Acquisition Of Apogee TherapeuticsSeptember 3, 2026 | rttnews.comAbbVie seals $11B acquisition of Apogee TherapeuticsSeptember 3, 2026 | msn.comAbbVie Completes Acquisition of Apogee TherapeuticsSeptember 3, 2026 | prnewswire.comApogee Therapeutics, Inc.(NasdaqGM:APGE) dropped from S&P TMI IndexSeptember 2, 2026 | marketscreener.comMThis Apogee Therapeutics Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For WednesdayAugust 12, 2026 | benzinga.comApogee Therapeutics: Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline UpdatesAugust 10, 2026 | finanznachrichten.deCarl Dambkowski Sells 5,500 Shares of Apogee Therapeutics (NASDAQ:APGE) StockAugust 8, 2026 | insidertrades.comIs Apogee Therapeutics (APGE) Fully Priced, Or Still A Bargain?August 3, 2026 | finance.yahoo.comAbbVie falls after 2026 guidance cut to reflect Apogee buyoutJuly 31, 2026 | msn.comAbbVie Trims Full-Year Profit Outlook Due to Apogee AcquisitionJuly 31, 2026 | finance.yahoo.comApogee Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apogee Therapeutics, Inc. - APGEJuly 30, 2026 | businesswire.comWhat This Apogee Insider Move Might Mean After a 247% Stock RunJuly 12, 2026 | finance.yahoo.comApogee Therapeutics (NASDAQ:APGE) CEO Sells $2,672,600.00 in StockJuly 11, 2026 | insidertrades.comApogee Therapeutics (APGE) Jumps Into Focus, Is The Stock Fully Valued?July 10, 2026 | uk.finance.yahoo.comShareholder Alert: Ademi LLP investigates whether Apogee Therapeutics is obtaining a Fair Price for Public ShareholdersJuly 2, 2026 | globenewswire.comApogee Therapeutics (NASDAQ:APGE) Insider Carl Dambkowski Sells 26,400 Shares of StockJune 25, 2026 | insidertrades.comApogee Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apogee Therapeutics, Inc. - APGEJune 24, 2026 | businesswire.comApogee Therapeutics Inc APGEJune 23, 2026 | morningstar.comMWhy did INTC, KEEL, APGE stocks hit 52-week highs today?June 22, 2026 | msn.comStock Market Today, June 22: Apogee Therapeutics Soars on AbbVie Cash Buyout OfferJune 22, 2026 | fool.comSHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Apogee Therapeutics, Inc. (NASDAQ: APGE)June 22, 2026 | prnewswire.comStocks making the biggest moves premarket: Apogee Therapeutics, SpaceX, Arcosa & moreJune 22, 2026 | cnbc.comAs AbbVie eyes Apogee, these biotech stocks earn the highest Quant ratingsJune 22, 2026 | seekingalpha.comAbbVie Strikes $10.9 Billion Deal for Apogee to Strengthen Future Immunology Portfolio (ABBV)June 22, 2026 | finance.yahoo.comShareholder Alert: Ademi LLP investigates whether Apogee Therapeutics is obtaining a Fair Price for Public ShareholdersJune 22, 2026 | prnewswire.comAbbVie to acquire Apogee Therapeutics in $10.9B dealJune 22, 2026 | proactiveinvestors.comAPGE Stock Alert: Halper Sadeh LLC is Investigating Whether Apogee Therapeutics, Inc. is Obtaining a Fair Price for its ShareholdersJune 22, 2026 | businesswire.com5 Things to Know Before the Stock Market OpensJune 22, 2026 | investopedia.comAbbVie to Buy Apogee Therapeutics for $10.9 Billion in CashJune 22, 2026 | wsj.comApogee Therapeutics Stock Soars. It's Being Bought by AbbVie for $10.9 Billion.June 22, 2026 | barrons.comAbbVie strikes $10.9 billion deal for Apogee TherapeuticsJune 22, 2026 | reuters.comIntel, Micron, SpaceX, Apogee Therapeutics, and More Stocks That Explain Today's MarketJune 22, 2026 | barrons.comAbbVie's Apogee deal, its biggest since 2019, could land soonJune 21, 2026 | msn.comAbbVie nears $11 billion deal for Apogee Therapeutics, FT reportsJune 19, 2026 | reuters.comApogee Therapeutics (NASDAQ:APGE) CEO Michael Thomas Henderson Sells 20,000 SharesJune 13, 2026 | insidertrades.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Apogee Therapeutics (APGE), Inventiva (IVA) and Roche Holding AG (OtherRHHVF)June 10, 2026 | theglobeandmail.comApogee Therapeutics, Inc. (APGE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptJune 10, 2026 | seekingalpha.comApogee (APGE) Secures Up to $1.3B in Non-Dilutive Financing from Blackstone to Advance ZumilokibartJune 5, 2026 | finance.yahoo.comThese 10 mid-cap U.S. healthcare companies carry the market's most expensive valuationsJune 2, 2026 | seekingalpha.comAssessing Apogee Therapeutics (APGE) Valuation After Positive Phase 2 APEX Results For ZumilokibartJune 1, 2026 | finance.yahoo.comApogee Therapeutics, Inc. (APGE) Discusses Positive Part B Results From Phase 2 APEX Trial of Zumilokibart in Atopic Dermatitis TranscriptJune 1, 2026 | seekingalpha.comApogee Therapeutics, Inc. (APGE) Discusses Positive Part B Results From Phase 2 APEX Trial of Zumilokibart in Atopic Dermatitis - SlideshowMay 30, 2026 | seekingalpha.comApogee Therapeutics: Charging Toward Pivotal Eczema Trial With Extended DosingMay 28, 2026 | seekingalpha.comApogee Therapeutics to Participate in Upcoming June ConferencesMay 28, 2026 | globenewswire.comApogee Therapeutics lines up $1.3B strategic financing for zumilokibart programMay 28, 2026 | proactiveinvestors.comApogee secures up to $1.3 billion from Blackstone to advance eczema drugMay 28, 2026 | reuters.com Apogee Therapeutics Media Mentions By Week Apogee Therapeutics Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APGE News Sentiment▼0.000.48▲Average Healthcare News Sentiment Apogee Therapeutics News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APGE Articles This Week▼05▲APGE Articles Average Week Apogee Therapeutics Trends on MarketBeatThis week vs. last weekSearches1Page Views1,520-20% Get Apogee Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APGE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ALNY News Today ROIV News Today GMAB News Today UTHR News Today INCY News Today BNTX News Today INSM News Today EXEL News Today ASND News Today HALO News Today News and Trends Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Apogee Therapeutics dated 10/13/2026. From Our PartnersTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billi...Banyan Hill Publishing | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apogee Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apogee Therapeutics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
